These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 34121410)
21. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols. Hu Y; Zeng F Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642 [TBL] [Abstract][Full Text] [Related]
22. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells. Tian H; Huang Y; He J; Zhang M; Ni P ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854 [TBL] [Abstract][Full Text] [Related]
23. Carrier-free Janus nano-prodrug based on camptothecin and gemcitabine: Reduction-triggered drug release and synergistic in vitro antiproliferative effect in multiple cancer cells. Xu Y; Huang Y; Zhang X; Lu W; Yu J; Liu S Int J Pharm; 2018 Oct; 550(1-2):45-56. PubMed ID: 30138703 [TBL] [Abstract][Full Text] [Related]
24. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release. Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423 [TBL] [Abstract][Full Text] [Related]
26. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy. Wang Z; Wu H; Liu P; Zeng F; Wu S Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754 [TBL] [Abstract][Full Text] [Related]
27. Dual-Responsive Polyprodrug Nanoparticles with Cascade-Enhanced Magnetic Resonance Signals for Deep-Penetration Drug Release in Tumor Therapy. Hao Q; Wang Z; Zhao W; Wen L; Wang W; Lu S; Xing D; Zhan M; Hu X ACS Appl Mater Interfaces; 2020 Nov; 12(44):49489-49501. PubMed ID: 33079514 [TBL] [Abstract][Full Text] [Related]
28. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy. Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855 [TBL] [Abstract][Full Text] [Related]
29. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy. Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685 [TBL] [Abstract][Full Text] [Related]
30. Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells. Su H; Zhang P; Cheetham AG; Koo JM; Lin R; Masood A; Schiapparelli P; Quiñones-Hinojosa A; Cui H Theranostics; 2016; 6(7):1065-74. PubMed ID: 27217839 [TBL] [Abstract][Full Text] [Related]
31. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery. Li Y; Lu H; Liang S; Xu S ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440 [TBL] [Abstract][Full Text] [Related]
32. Glutathione Triggered Cascade Degradation of an Amphiphilic Poly(disulfide)-Drug Conjugate and Targeted Release. Bej R; Ghosh S Bioconjug Chem; 2019 Jan; 30(1):101-110. PubMed ID: 30557508 [TBL] [Abstract][Full Text] [Related]
33. Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery. Bai S; Gao YE; Ma X; Shi X; Hou M; Xue P; Kang Y; Xu Z Carbohydr Polym; 2018 Feb; 182():235-244. PubMed ID: 29279120 [TBL] [Abstract][Full Text] [Related]
34. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency. Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396 [TBL] [Abstract][Full Text] [Related]
35. Development of a novel sialic acid-conjugated camptothecin prodrug for enhanced cancer chemotherapy. Dong H; Huang X; Wu X Biomater Sci; 2023 Sep; 11(18):6160-6166. PubMed ID: 37548235 [TBL] [Abstract][Full Text] [Related]
36. Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy. Sun B; Luo C; Zhang X; Guo M; Sun M; Yu H; Chen Q; Yang W; Wang M; Zuo S; Chen P; Kan Q; Zhang H; Wang Y; He Z; Sun J Nat Commun; 2019 Jul; 10(1):3211. PubMed ID: 31324811 [TBL] [Abstract][Full Text] [Related]
37. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery. Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046 [TBL] [Abstract][Full Text] [Related]
38. Mechanistic study of the covalent loading of paclitaxel via disulfide linkers for controlled drug release. Yuan L; Chen W; Hu J; Zhang JZ; Yang D Langmuir; 2013 Jan; 29(2):734-43. PubMed ID: 23252889 [TBL] [Abstract][Full Text] [Related]
39. Gemcitabine-camptothecin conjugates: a hybrid prodrug for controlled drug release and synergistic therapeutics. Hou M; Xue P; Gao YE; Ma X; Bai S; Kang Y; Xu Z Biomater Sci; 2017 Aug; 5(9):1889-1897. PubMed ID: 28681888 [TBL] [Abstract][Full Text] [Related]
40. A series of alpha-amino acid ester prodrugs of camptothecin: in vitro hydrolysis and A549 human lung carcinoma cell cytotoxicity. Deshmukh M; Chao P; Kutscher HL; Gao D; Sinko PJ J Med Chem; 2010 Feb; 53(3):1038-47. PubMed ID: 20063889 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]